Payload Information

General Information of This Payload

Payload ID	PAY0YBCFH
Name	Tubulysin 8
Synonyms	Tubulysin H; 799822-09-6; EX-A5466H; HY-N7051; AKOS040740946; CS-0101874 Click to Show/Hide
Target(s)	Microtubule (MT)			Target Info
Structure
Structure	3D MOL		2D MOL
Formula	C40H59N5O9S
Isosmiles	CC[C@H](C)[C@@H](C(=O)N(COC(=O)C)[C@H](C[C@H](C1=NC(=CS1)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](C)C(=O)O)OC(=O)C)C(C)C)NC(=O)[C@H]3CCCCN3C
PubChem CID	11411735
InChI	InChI=1S/C40H59N5O9S/c1-9-25(4)35(43-37(49)32-17-13-14-18-44(32)8)39(50)45(23-53-27(6)46)33(24(2)3)21-34(54-28(7)47)38-42-31(22-55-38)36(48)41-30(19-26(5)40(51)52)20-29-15-11-10-12-16-29/h10-12,15-16,22,24-26,30,32-35H,9,13-14,17-21,23H2,1-8H3,(H,41,48)(H,43,49)(H,51,52)/t25-,26-,30+,32+,33+,34+,35-/m0/s1
InChIKey	CYTBBNFQKZOQJE-YRKZXFTRSA-N
IUPAC Name	(2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[acetyloxymethyl-[(2S,3S)-3-methyl-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]pentanoyl]amino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-2-methyl-5-phenylpentanoic acid
Pharmaceutical Properties	Molecule Weight	786	Polar area	213
	Complexity	1300	xlogp Value	3.7
	Heavy Count	55	Rot Bonds	22
	Hbond acc	12	Hbond Donor	3

Each Antibody-drug Conjugate Related to This Payload

Full Information of The Activity Data of The ADC(s) Related to This Payload

Alpha-CD30-8 [Investigative]

ADC Info

Discovered Using Cell Line-derived Xenograft Model

Click To Hide/Show 2 Activity Data Related to This Level

Experiment 1 Reporting the Activity Date of This ADC					[1]
Efficacy Data	Tumor Growth Inhibition value (TGI)	≈ 97.10% (Day 28)	Positive CD30 expression (CD30+++/++)
Method Description	Alpha-CD30-8 (0.3 m ug/kg, every seven days x3) induces efficient tumor cell killing in cell line-derived models of CD30+, MDR-L540cy HL cells with CD30 expression with high expression.
In Vivo Model	L540cy CDX model
In Vitro Model	Hodgkin's disease	L540cy cells		Homo sapiens
Experiment 2 Reporting the Activity Date of This ADC					[1]
Efficacy Data	Tumor Growth Inhibition value (TGI)	≈ 99.20% (Day 16)	Positive CD30 expression (CD30+++/++)
Method Description	Alpha-CD30-8 (1 m ug/kg, every seven days x3) induces efficient tumor cell killing in cell line-derived models of CD30+, MDR+ DEL/BVR ALCL cells with CD30 expression with high expression.
In Vivo Model	DEL/BVR CDX model
In Vitro Model	Anaplastic large cell lymphoma	DEL/BVR cells		CVCL_1170

References

Ref 1	Glucuronide-Linked Antibody-Tubulysin Conjugates Display Activity in MDR(+) and Heterogeneous Tumor Models. Mol Cancer Ther. 2018 Aug;17(8):1752-1760. doi: 10.1158/1535-7163.MCT-18-0073. Epub 2018 Jun 4.